{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:01:09Z","timestamp":1740146469189,"version":"3.37.3"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0209350","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T22:52:32Z","timestamp":1546901552000},"page":"e0209350","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0722-3122","authenticated-orcid":true,"given":"Oliver","family":"Grottke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"van Ryn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Zentai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanfa","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Honickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Rossaint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri M. H.","family":"Spronk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13054-016-1265-x","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition","volume":"20","author":"R Rossaint","year":"2016","journal-title":"Crit Care"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/TA.0b013e3181877a9c","article-title":"The coagulopathy of trauma: a review of mechanisms","volume":"65","author":"JR Hess","year":"2008","journal-title":"J Trauma"},{"issue":"20","key":"ref3","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/CIRCULATIONAHA.112.123224","article-title":"Periprocedural management and approach to bleeding in patients taking dabigatran","volume":"126","author":"JI Weitz","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"CV Pollack Jr.","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"ref5","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood-2012-11-468207","article-title":"A specific antidote for dabigatran: functional and structural characterization","volume":"121","author":"F Schiele","year":"2013","journal-title":"Blood"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1160\/TH14-12-1080","article-title":"A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran","volume":"113","author":"S Glund","year":"2015","journal-title":"Thromb Haemost"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1160\/TH16-05-0385","article-title":"Idarucizumab does not have procoagulant effects: Assessment of thrombosis biomarkers in healthy volunteers","volume":"117","author":"M Schmohl","year":"2017","journal-title":"Thromb Haemost"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jacc.2015.07.051","article-title":"Idarucizumab, a specific dabigatran reversal agent, reduces blood loss in a porcine model of trauma with dabigatran anticoagulation","volume":"66","author":"O Grottke","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MCC.0000000000000115","article-title":"Fluid resuscitation in trauma patients: what should we know?","volume":"20","author":"S Coppola","year":"2014","journal-title":"Curr Opin Crit Care"},{"key":"ref10","unstructured":"European Medicines Agency. Hydroxyethyl starch solutions for infusion. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Hydroxyethyl_starch-containing_solutions\/human_referral_prac_000012.jsp&mid=WC0b01ac05805c516f\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Hydroxyethyl_starch-containing_solutions\/human_referral_prac_000012.jsp&amp;mid=WC0b01ac05805c516f<\/ext-link> [Accessed April 2018]."},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/cc8960","article-title":"Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury","volume":"14","author":"O Grottke","year":"2010","journal-title":"Crit Care"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood-2011-03-343046","article-title":"Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury","volume":"118","author":"O Grottke","year":"2011","journal-title":"Blood"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/bja\/aeq263","article-title":"Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs","volume":"105","author":"O Grottke","year":"2010","journal-title":"Br J Anaesth"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MBC.0b013e32834f1b0c","article-title":"Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran","volume":"23","author":"J Stangier","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2125.2007.02899.x","article-title":"The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects","volume":"64","author":"J Stangier","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003088-200847010-00005","article-title":"Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects","volume":"47","author":"J Stangier","year":"2008","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"SJ Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"H Heidbuchel","year":"2015","journal-title":"Europace"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/bja\/aeq084","article-title":"Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial","volume":"104","author":"A Schramko","year":"2010","journal-title":"Br J Anaesth"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00134-011-2385-z","article-title":"Influence of hydroxyethyl starch (HES) 130\/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review","volume":"37","author":"CS Hartog","year":"2011","journal-title":"Intensive Care Med"},{"issue":"31","key":"ref21","doi-asserted-by":"crossref","first-page":"e4498","DOI":"10.1097\/MD.0000000000004498","article-title":"Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: A systematic review and stratified meta-analysis","volume":"95","author":"KC Rasmussen","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0003-4975(01)02745-X","article-title":"Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding","volume":"72","author":"MM Wilkes","year":"2001","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cll.2014.06.008","article-title":"Measurement of dabigatran in standardly used clinical assays, whole blood viscoelastic coagulation, and thrombin generation assays","volume":"34","author":"J van Ryn","year":"2014","journal-title":"Clin Lab Med"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/TA.0b013e3181b06364","article-title":"Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model","volume":"68","author":"G Dickneite","year":"2010","journal-title":"J Trauma"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0209350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:11:55Z","timestamp":1588965115000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0209350"}},"subtitle":[],"editor":[{"given":"Nienke","family":"van Rein","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0209350","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,1,7]]}}}